Prevent Cardiac Surgery Associated AKI Trial
Recruiting
Phase 2
Interventional Study
Renal Failure
Coronary Artery Disease
Surgery
Surgery-Complications
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 242 (estimated)
- Sponsor
- George Washington University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prevent CSA-AKI (Cardiac Surgery Associated Acute Kidney Injury) trial is a double blinded randomized controlled trial, 242 patients undergoing elective cardiopulmonary bypass surgery (CPB)will either receive a placebo or daily 1200 mg of Co enzyme Q10 (CoQ10) and 1000 mg of Glutathione (GSH), the first dose will be given the day before surgery and continues while admitted up to 1 week. Blood and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult 18-70 years of age
* Undergoing elective CPB (Cardiopulmonary Bypass) surgery
* Baseline GFR (Glomerular Filtration Rate) ≥45 ml/min
Exclusion Criteria:
* GFR (Glomerular Filtration Rate) \<45 ml/min
* Solitary kidney
* Status post-kidney transplant
* Pregnant women
* …
Contacts
Yoosif Abdalla, MD
CONTACT